Published in:
Open Access
01-06-2018 | Journal club
Monoclonal antibodies for migraine: an update
Authors:
Daniel Castle, Neil P. Robertson
Published in:
Journal of Neurology
|
Issue 6/2018
Login to get access
Excerpt
Migraine is an episodic neurological disorder resulting in attacks of headache associated with neurological symptoms. Whilst episodes of migraine are debilitating for the patient, they also result in a significant burden for society as a whole. The World Health Organisation now ranks migraine as the third most prevalent medical condition in the world, and the second most disabling neurological condition. The economic cost of migraine is also considerable and has an estimated worldwide annual cost of $20 billion, relating to healthcare, procedures and loss of productivity. …